Copy of Newspaper Cuttings of the Standalone and Consolidated Audited Financial Results for the quarter and year Ended 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeevan Scientific Technology Limited has submitted to BSE the newspaper clippings (published in Andhra Prabha and Business Standard on May 31, 2025) of its audited standalone and consolidated financial results for Q4 FY25 and full-year FY25, which were approved by the Board on May 30, 2025. For the quarter ended March 31, 2025, the company reported a profit after tax of about ₹5.43 lakh compared to a loss of around ₹39.13 lakh in Q4 FY24, despite revenue dipping to roughly ₹540 lakh from ₹583 lakh. For the full year FY25, standalone revenue fell to about ₹2,152 lakh (from ₹2,283 lakh in FY24), but the company swung to a PAT of roughly ₹30.74 lakh versus a loss of about ₹60.63 lakh in FY24, driven by lower total expenses (around ₹2,072 lakh vs ₹2,223 lakh). Consolidated FY25 figures are broadly similar to standalone, indicating limited subsidiary contribution. Basic and diluted EPS improved to about ₹4.06 for FY25 versus a negative ₹8.07 in FY24.
This is a routine compliance filing re-publishing already approved results, so no new information is being announced; however, the headline turnaround from a loss to a profit on both quarterly and yearly bases is a positive signal for shareholders, though the absolute profit amounts are very small relative to the revenue base and the top line continues to shrink.